1.
Baghrous S, Ghicha I, Bousselham F, et al. Beyond Current Therapies: In Silico Drug Repurposing as a Strategy to Overcome Tyrosine Kinase Inhibitor Resistance in NSCLC. J. Drug Delivery Ther. 2025;15(8):207-216. doi:10.22270/jddt.v15i8.7276